Real-World Survival Outcomes Following Chemoradiotherapy with or Without Durvalumab in PD-L1-Defined Subgroups of Stage III Unresectable NSCLC.
Saved in:
| Title: | Real-World Survival Outcomes Following Chemoradiotherapy with or Without Durvalumab in PD-L1-Defined Subgroups of Stage III Unresectable NSCLC. |
|---|---|
| Authors: | Selke, Janne1 (AUTHOR), Dzierma, Yvonne1,2 (AUTHOR), Manda, Katrin1 (AUTHOR), Hildebrandt, Guido1 (AUTHOR), Frerker, Bernd1 (AUTHOR), Kalata, Paul1 (AUTHOR), Ackermann, Christin2 (AUTHOR), Bock, Felix1 (AUTHOR) felix.bock@med.uni-rostock.de |
| Source: | Current Oncology. Jun2026, Vol. 33 Issue 6, p351. 15p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 194912127 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Real-World Survival Outcomes Following Chemoradiotherapy with or Without Durvalumab in PD-L1-Defined Subgroups of Stage III Unresectable NSCLC. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Selke%2C+Janne%22">Selke, Janne</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Dzierma%2C+Yvonne%22">Dzierma, Yvonne</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Manda%2C+Katrin%22">Manda, Katrin</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hildebrandt%2C+Guido%22">Hildebrandt, Guido</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Frerker%2C+Bernd%22">Frerker, Bernd</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kalata%2C+Paul%22">Kalata, Paul</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ackermann%2C+Christin%22">Ackermann, Christin</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bock%2C+Felix%22">Bock, Felix</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> felix.bock@med.uni-rostock.de</i> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Current+Oncology%22">Current Oncology</searchLink>. Jun2026, Vol. 33 Issue 6, p351. 15p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=194912127 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3390/curroncol33060351 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 15 StartPage: 351 Titles: – TitleFull: Real-World Survival Outcomes Following Chemoradiotherapy with or Without Durvalumab in PD-L1-Defined Subgroups of Stage III Unresectable NSCLC. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Selke, Janne – PersonEntity: Name: NameFull: Dzierma, Yvonne – PersonEntity: Name: NameFull: Manda, Katrin – PersonEntity: Name: NameFull: Hildebrandt, Guido – PersonEntity: Name: NameFull: Frerker, Bernd – PersonEntity: Name: NameFull: Kalata, Paul – PersonEntity: Name: NameFull: Ackermann, Christin – PersonEntity: Name: NameFull: Bock, Felix IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 06 Text: Jun2026 Type: published Y: 2026 Identifiers: – Type: issn-print Value: 11980052 Numbering: – Type: volume Value: 33 – Type: issue Value: 6 Titles: – TitleFull: Current Oncology Type: main |
| ResultId | 1 |